Dr. Dong Xiaoliang, born in May 1990, graduated with a combined Master's and Ph.D. from the School of Life Sciences, Nanjing University, specializing in Physiology. He obtained his Ph.D. in Biology in June 2019. From 2019 to 2021, he conducted postdoctoral research at the School of Medicine, Jiangnan University, Wuxi. In July 2021, he joined the School of Medicine, Jiangnan University, as a lecturer. Dr. Dong's research has focused on the pharmacology of anti-inflammatory immunology. He has published multiple SCI papers as the first author in renowned international journals such asCell Death and DifferentiationandAntioxidants (Basel). He has participated in numerous national and provincial research projects and currently leads a project funded by the National Natural Science Foundation of China's Youth Fund. Dr. Dong also serves as a member of the Pharmacological Society of Jiangsu Province's Committee on Anti-inflammatory Immunopharmacology. |
